Enzelo 10000 Capsule DR contains Pancreatin 170 mg, a combination of digestive enzymes including amylase, lipase, and protease, designed to aid in the digestion of carbohydrates, fats, and proteins. This delayed-release formulation ensures the enzymes are protected from gastric acid, allowing them to be released in the intestine where they exert their therapeutic effect. Enzelo 10000 is indicated for patients with pancreatic exocrine insufficiency resulting from conditions such as chronic pancreatitis, cystic fibrosis, pancreatic surgery, or other disorders impairing pancreatic enzyme production. By supplementing endogenous enzymes, Enzelo 10000 helps improve nutrient absorption, reduces symptoms of malabsorption such as steatorrhea, bloating, and abdominal discomfort, and supports overall nutritional status. The dosage and duration of therapy should be individualized based on the severity of enzyme deficiency and clinical response. It is important to administer the capsules with meals or snacks to optimize enzyme activity. Enzelo 10000 is generally well tolerated; however, patients should be monitored for potential adverse effects including gastrointestinal disturbances or allergic reactions. Use with caution in individuals with known hypersensitivity to pancreatin or any component of the formulation. Consultation with a healthcare professional is recommended prior to initiating therapy to ensure appropriate use and monitoring.